D espite the availability of effective human and animal vaccines against rabies, and other measures for its control, rabies continues to account for at least 55,000 human deaths each year, mainly in the developing countries of Africa and Asia (1, 2) . In these countries, most human rabies infections result from exposure to infected dogs, by bites, scratches, and mucosal exposures (3) . Rabies vaccination of animals and postexposure prophylaxis (PEP) for humans is prohibitively expensive for most African governments, and it has long been contended that the effects of rabies are underestimated in Africa (4) .
Typical furious rabies occurs as an encephalitis, often with characteristic features such as hydrophobia and salivation, following a brief, nonspecifi c, febrile prodrome. Less commonly, rabies may occur in the paralytic form in which characteristic clinical features may be absent (3, 5) .
Limpopo is the northernmost province in South Africa and shares borders with Zimbabwe and Botswana. To the East, Limpopo is fl anked by the Kruger National Park and Mozambique (Figure 1 ). The climate is variable with temperate and subtropical areas, and most of the population live in rural villages and subsist by farming maize and livestock.
Since the 1970s, most human rabies cases in South Africa have occurred in KwaZulu-Natal Province, where the major animal vector is the domestic dog (6) . Human rabies is much less common in areas such as Limpopo Province, where the major animal vectors are wild animals such as the black-backed jackal species (Canis mesomelas), because these animals are less likely to come into contact with humans. Before this report, the most recent 2 laboratory-confi rmed human rabies cases in Limpopo Province occurred in 1980 and 1981 (R. Swanepoel, pers. comm.). We describe the epidemiologic, clinical, and viral molecular features of an outbreak of rabies in Limpopo Province, South Africa, in [2005] [2006] .
Methods

Animal Rabies Surveillance
Brain specimens from all animals with suspected rabies in South Africa were submitted to the Rabies Reference Laboratory at Onderstepoort Veterinary Institute, Pretoria. Routine data collected included species, location of case-patient, and date of specimen collection. Archived data on confi rmed animal rabies cases from Limpopo since January 1994 were reviewed. An animal case was defi ned as any case that was laboratory confi rmed by fl uorescent antibody test (FAT) (7) or virus isolation after specimen inoculation into suckling mice and monitoring for signs of rabies infection over 28 days.
Dog vaccine coverage was estimated as the number of doses of vaccine administered to dogs per year divided by the estimated dog population. A ratio of 7 persons to 1 dog was used to estimate the dog population based on unpublished survey data (E. Dyason, pers. comm.). Estimates of the human population by district were supplied by Statistics South Africa (Stats SA, Pretoria, South Africa).
Human Rabies Surveillance
Human rabies is notifi able in South Africa (Health Act No. 63, 1977) ; diagnostic specimens from suspected casepatients were submitted to the Special Pathogens Unit at the National Institute for Communicable Diseases, Johannesburg. The diagnosis of rabies was confi rmed by using FAT on brain tissue (7); by using a heminested reverse transcriptase-PCR (RT-PCR) of saliva (8) ; or by isolating virus from brain, saliva, and cerebrospinal fl uid (CSF) specimens as described above. Serum and CSF specimens received were tested for antirabies antibodies, and CSF specimens were tested for viral RNA by RT-PCR. Serologic testing was performed by using indirect immunofl uorescence (9) .
Epidemiologic Investigation of Human Cases
The study team visited hospitals in the outbreak area in February 2006. Potential cases of rabies (meeting the clinical case defi nition) in the previous 12 months were identifi ed by clinician interviews, and prospective active surveillance was introduced for new suspected rabies cases.
Data were collected on a standardized data collection form and included demographic data, clinical and laboratory features, history of animal exposure, management of the initial bite exposure, and patient outcomes (Table) . Data were obtained by review of clinical records and interview of attending clinicians. For 3 probable cases, no clinical records or laboratory results were available, and data were obtained only by interview of the attending clinician. Data on the cost and numbers of doses of vaccine and immunoglobulin distributed in Limpopo Province were obtained from relevant manufacturers.
Case Defi nitions
Clinical case. A clinical case-patient was defi ned as any person who died after January 1, 2005, and who resided in Limpopo Province before onset of illness with 1 of the following clinical symptoms-delirium, hydrophobia, salivation, acute psychosis, acute fl accid paralysis, muscle spasms, convulsion or respiratory paralysis-and with no other identifi ed cause of death.
Possible case. A possible case-patient was defi ned as a person who met the clinical case defi nition, but whose case was not laboratory confi rmed, and who had no documented history of animal exposure.
Probable case. A probable case-patient was defi ned as a person who met the clinical case defi nition, but whose case was not laboratory confi rmed, and who had history of exposure to a suspected rabid animal.
Confi rmed case. A confi rmed case-patient was defi ned as a person who met the clinical case defi nition and had laboratory-confi rmed rabies.
Molecular Analysis of Viruses Obtained from Animal and Human Rabies Case-Patients
After viral RNA underwent extraction and RT-PCR (10, 11) , the amplicons obtained were purifi ed with a com- mercial kit (Wizard SV Gel and PCR Clean-Up System, Promega, Madison, WI, USA) and sequenced bidirectionally on an ABI377 automated DNA sequencer (Applied Biosystems, Foster City, CA, USA) with the G/L primer set. A 592-bp nucleotide portion of the cytoplasmic domain of the glycoprotein and the G-L intergenic region of the virus isolates included in the study sample were aligned in ClustalW (12) . A phylogenetic tree was constructed with the neighbor-joining method (13) in MEGA (Molecular Evolutionary Genetics Analysis) software version 2.1 (14) , and 1,000 replications. The phylogenetic tree was visualized with TreeView (15) . All available isolates from humans and a panel of dog rabies virus isolates from Vhembe were selected (online Appendix Table, available from www.cdc.gov/EID/content/ 13/12/1879-appT.htm). Virus isolates from other provinces in South Africa and neighboring countries were also included in phylogenetic reconstruction of the molecular epidemiology. 
Results
Animal Rabies Cases
Human Rabies Cases
Detection of the Outbreak
Rabies was confi rmed by RT-PCR testing on a saliva specimen from the index case-patient, a 10-year-old boy who was brought to the hospital on February 7, 2006 (Figure 3) . Twelve patients with encephalitis that met the case defi nition were identifi ed retrospectively, and rabies was confi rmed by IFA for 2 of these patients for which brain tissue was available and by RT-PCR of saliva for a further 2 patients. The earliest identifi ed case-patient was a 9-yearold boy who was admitted in August 2005 with a history of dog bite. An admission CSF specimen, submitted for rabies diagnosis, was found to be negative by both RT-PCR and antibody testing. Twenty-seven cases were in children 3-12 years of age (median 9 years). All case-patients were hospitalized. The median duration from admission to death was 4 days (range 1-25 days). All 4 patients who survived >10 days were admitted to intensive care units.
Clinical and Laboratory Features of Human Cases
The median incubation period was 8 weeks (range 3-28 weeks) for the 22 case-patients for whom the date of exposure was known. The most common clinical feature observed in patients with confi rmed cases was salivation (19/21, 90%), followed by agitation (14/21, 67%), weakness (14/21, 67%), fever (14/21, 67%), and hallucinations (11/21, 52%) (Table) .
The median period between when a person fi rst experienced illness and when the person sought healthcare was 2 days (range 0-8 days) in the 19 patients for whom date of onset of symptoms was available. Lumbar puncture was performed on 14 patients. CSF fi ndings were within normal limits for all 11 patients who did not have blood in the CSF specimen. Nine of 19 patients tested (47%) had an elevated leukocyte count (>10 ×10 9 /L), and 11 (61%) of 18 had elevated urea levels (>7 mmol/L). All 4 patients tested for HIV were HIV seronegative. No abnormalities were detected in hemoglobin level, platelet count, or erythrocyte sedimentation rate in any of the 19 patients.
The cluster of 11 case-patients who sought treatment before the index case-patient was identifi ed (excluding the primary case-patient in whom rabies was suspected) was reviewed separately to identify possible reasons for the delayed diagnosis of rabies. Of these patients, 6 reported having consulted a traditional healer before visiting the clinic. Clinical and laboratory data were available for 8 patients: 6 exhibited prominent abdominal symptoms (including abdominal distension in 4, vomiting in 3, and diarrhea in 2), 3 of whom reported consulting a traditional healer. Liver function tests were performed for 7 case-patients; of these, 6 had elevated alkaline phosphatase enzyme levels (>120 IU/L). Clinicians' differential diagnoses of these cases included viral encephalitis, typhoid, pyrexia of unknown origin, epilepsy, panic attacks, poisoning or toxin exposure, and Guillain-Barré syndrome. Five patients were not asked about possible animal exposures. For 7 case-patients reported in this outbreak, specimens were not submitted for rabies diagnosis. For all 21 confi rmed case-patients, saliva specimens were positive by RT-PCR; for 7 of these case-patients, brain tissue specimens sampled on postmortem examination were also positive by IFA, and for 3 unvaccinated patients, serum specimens were positive for rabies antibodies. Virus isolation was attempted on 7 saliva specimens and was successful for 5. No virus isolation was attempted on brain specimens because all were received in formalin, despite guidelines for submission of samples in glycerol saline. All 7 CSF specimens were collected during the fi rst week of illness and were negative for antirabies antibodies and by RT-PCR. A saliva specimen from 1 patient with typical rabies symptoms, who had been bitten by a dog with suspected rabies, tested negative by RT-PCR. He was classifi ed as a probable case-patient; postmortem brain tissue could not be obtained.
Management of Exposures
All 24 case-patients who were asked about a history of animal exposure reported an exposure to a potentially rabid dog. All documented exposures were category 3 (high-risk) exposures, i.e., a bite or scratch that drew blood or a lick to mucous membranes or broken skin. Most patients (20/24, 83%) reported a bite, but 3 patients reported scratches only, and 1 reported that the dog had licked and nibbled at mucous membranes. For 22 case-patients with a known date of exposure, 15 (68%) exposures had occurred before the outbreak was identifi ed and control measures were implemented.
Of 16 case-patients for whom site of exposure was reported, half of the exposures (8) were on the lower limb, but exposures were also reported to the upper limb (3), trunk (2), and head and neck (3). Most exposures were to unknown dogs, but 5 of 20 case-patients reported exposure to their own dog. Of the 18 case-patients able to give a history of the management of the original bite exposure, 12 (67%) did not report to a clinic at the time of exposure. All 6 case-patients who sought treatment at clinics received wound cleaning, but only 2 were vaccinated (1 received only 1 dose).
One case-patient, a 4-year-old boy who had been bitten on the left cheek by a dog on 
Molecular Epidemiology
Phylogenetic analysis of nucleotide sequences indicated that the viruses originating from humans in the Vhembe area of Limpopo were genetically indistinguishable from those obtained from domestic dogs in the same geographic area (Figure 4) . Notably, this cluster represented a new phylogenetic group not previously encountered in Limpopo Province (16) and clearly distinct from the viruses isolated from C. mesomelas from Limpopo. Outbreak viruses were most closely related to viruses obtained from dogs and jackals across the border in southern Zimbabwe (sublineage A1). A second closely related sublineage (A2) was composed of viruses from southeastern Zimbabwe and western Mozambique, which suggests that a dog rabies cycle exists within South Africa, Zimbabwe, and Mozambique. The inclusion and analysis of rabies virus isolates from other provinces of South Africa and neighboring countries did not suggest any close link with the outbreak viruses.
Control Measures
Central-point dog vaccination campaigns in villages in the affected area were intensifi ed after identifi cation of the increased numbers of rabies cases in domestic dogs. A community awareness program related to the hazards of dog bites and the importance of timely visits to the clinic for rabies postexposure prophylaxis was established in 
Discussion
We describe an outbreak of human rabies in a province of South Africa where rabies had been well controlled for >10 years. Late recognition of this outbreak resulted in delayed implementation of control measures. Although the clinical features of classic rabies have been described as unmistakable (5), the diagnosis may be missed due to low index of suspicion and variable clinical features (17) , as occurred in this outbreak. Cases of rabies may be incorrectly attributed to other causes of pyrexia and confusion common to rural Africa, including cerebral malaria, bacterial infections, and infection with HIV (18, 19) .
In this outbreak, the clinical signs and symptoms of the initial case-patients may have been altered due to use of traditional medicines. Of 12 case-patients in whom the diagnosis of rabies was missed, 6 reported having visited a traditional healer before seeking treatment at a hospital. The use of traditional medicines is common in rural settings in South Africa (20, 21) and may result in toxicities, including abdominal and psychiatric symptoms and abnormal liver function test results (22) . These medicines could have contributed to the atypical manifestations in some cases. In addition, clinicians may have attributed some of the neurologic symptoms to herbal intoxication.
Nevertheless, rabies was in fact suspected in the primary case-patient, identifi ed in August 2005. The diagnosis was not, however, confi rmed because an inappropriate specimen (a CSF specimen taken on admission) was submitted. Anti-rabies antibodies in the CSF are not usually detected <1 week after the onset of clinical illness, and RT-PCR results for rabies RNA on CSF may be negative in rabies cases; thus, a negative CSF result does not exclude the diagnosis of rabies (17, 18, 23) . It is therefore recommended that repeated saliva and serum specimens be submitted in addition to CSF and that a postmortem brain specimen be actively sought in all suspected rabies cases (18) .
Four case-patients who sought treatment at a clinic before identifi cation of the outbreak were not offered PEP, probably because the risk for rabies infection was not considered. Our case series includes 1 child in whom rabies developed despite the administration of seemingly adequate PEP. Possible contributing factors to the development of rabies in this case include the facial location of the wound, possible inadequate wound cleansing, and the fact that all of the immunoglobulin could not be infi ltrated into the wound site. The full dose of immunoglobulin should be administered on the fi rst day of PEP and should be infi ltrated into the wound (24, 25) .
Rabies of the canid biotype has been endemic in C. mesomelas in Limpopo Province since the 1950s, with occasional spillover to cattle and domestic dogs. Since 1952, several attempts at control have been made, including destroying ≈22,000 dogs in that year, poisoning an estimated 3,900 jackals from 1951 through 1956, and vaccinating 181,414 dogs from 1952 through 1962 (6) . Despite these efforts, a low incidence of dog rabies was observed in the province in the 1960s. Rabies became a serious problem again in cattle and jackals in the mid 1970s, likely following its reintroduction from Zimbabwe in 1974, and it has remained endemic in jackals with sporadic cases occurring in domestic dogs (6) .
As in a classic situation, this outbreak in humans followed an outbreak in domestic dogs of the region. Increasing numbers of human rabies cases in Africa have been attributed to increasing numbers in animals, to the mobility of human and animal populations, and to deteriorating infrastructure and resources for rabies control (4, 26) . Reasons for the reemergence of canine rabies in Limpopo after many years of effective disease control are unclear. In Zimbabwe, dog rabies cases increased after 1990, after declining vaccination coverage associated with decreased resources and diversion of resources (27) . Low vaccination coverage in domestic dogs in Limpopo over several years may have led to an accumulation of susceptible animals, which led to the reestablishment of transmission.
The reintroduction of canine rabies into northern KwaZulu-Natal Province in 1976 followed an infl ux of refugees from Mozambique (6) . The possible contribution of increased immigration into Limpopo Province from Zimbabwe in recent years is diffi cult to quantify (28) . Molecular genetic analysis indicates that the virus isolates from both humans and dogs in this outbreak were most closely related to those from southern Zimbabwe. This fi nding suggests that the outbreak may have extended across the border from Zimbabwe.
The number of human rabies cases in Limpopo Province decreased after May 2006; no further human cases had occurred as of June 30, 2007 . This decrease is likely due to the introduction of coordinated control measures (including aggressive PEP). Although highly effective if administered correctly, PEP is much more costly than vaccination of domestic dogs (29, 30) . Unfortunately, dog vaccination is diffi cult in many developing countries because of high dog turnover rates, shortages of funding and personnel, and competing priorities (26, 31) .
The number of reported human rabies cases, particularly in Africa, greatly underestimates the true effects of the disease. Contributing factors include failure to seek treatment at healthcare facilities, failure to make a laboratory diagnosis, and failure to report the disease (2, 32) . Our attempts to conduct active case fi nding through clinician interviews at hospitals in Vhembe District encountered several problems. First, we were unable to review all hospital admissions records because of incomplete record keeping. We also recognize that at least some infected persons may not have visited hospitals and died at home. In addition, epidemiologic data were not available for all cases since several cases were identifi ed retrospectively. An increased awareness of rabies after interventions for control may have contributed to increased case reporting after February 2006; this situation may have affected apparent trends in human case numbers and contributed to the delay in observed decline in dog cases.
This outbreak highlights the fact that rabies is a transboundary disease and can reemerge in areas where successful control programs have been active for many years. Clinicians should consider rabies in the differential diagnosis, especially in cases of fatal encephalitis and submit appropriate specimens for rabies diagnosis. Sustained awareness, together with political and economic commitment to animal and human rabies control programs, particularly the vaccination of dogs, is essential.
